MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma
JCO Precision Oncology | June 8, 2022 | Volume: No volume available | Issue: 6 | Pages: No page available
10.1200/po.22.00096
| PMID 35675576